Afuco™ Anti-Human SLC34A2 ADCC Therapeutic Antibody, ADCC Enhanced

Anti-SLC34A2 ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. The antibodies specifically directed against NaPi2b (SLC34A2) are used for treatment of tumors and cancer.
Supplier Creative Biolabs
Product # AFC-552CL
Pricing Inquiry
Host Humanized
Target SLC34A2
Species Reactivity Human
Type ADCC enhanced antibody
Storage ≥1 year at -20°C. If the reconstituted antibody cannot be used within two weeks, it should be aliquoted into smaller vials and stored at -20°C
Feedback